BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16263897)

  • 1. Deactivating implantable cardioverter defibrillators.
    Lynn J
    Ann Intern Med; 2005 Nov; 143(9):691; author reply 691. PubMed ID: 16263897
    [No Abstract]   [Full Text] [Related]  

  • 2. Deactivating implantable cardioverter defibrillators.
    Ross HM
    Ann Intern Med; 2005 Nov; 143(9):690; author reply 691. PubMed ID: 16263895
    [No Abstract]   [Full Text] [Related]  

  • 3. Deactivating implantable cardioverter defibrillators.
    Beattie JM; Connolly MJ; Ellershaw JE
    Ann Intern Med; 2005 Nov; 143(9):690-1; author reply 691. PubMed ID: 16263894
    [No Abstract]   [Full Text] [Related]  

  • 4. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
    Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
    Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
    [No Abstract]   [Full Text] [Related]  

  • 5. The ethics of deactivating implanted cardioverter defibrillators.
    Berger JT
    Ann Intern Med; 2005 Apr; 142(8):631-4. PubMed ID: 15838070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
    Pilkington BC
    J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
    Morgenweck CJ
    Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deactivation of advanced lifesaving technologies.
    Lipman HI
    Am J Geriatr Cardiol; 2007; 16(2):109-11. PubMed ID: 17342011
    [No Abstract]   [Full Text] [Related]  

  • 9. "Just Because We Can Doesn't Mean We Should": views of nurses on deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Ottenberg AL; Gerhardson S; Mueller LA; Kaufman SR; Koenig BA; Mueller PS
    J Interv Card Electrophysiol; 2011 Dec; 32(3):243-52. PubMed ID: 21805140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicians' views regarding deactivation of cardiovascular implantable electronic devices in seriously ill patients.
    Mueller PS
    Heart Rhythm; 2010 Nov; 7(11):1543-4. PubMed ID: 20816871
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
    Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
    Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 13. Deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Mitchell SL; Brock DW
    Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
    Gura MT
    AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 16. [Deactivating pacemakers in terminally ill patients].
    Hotvedt R
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1680. PubMed ID: 18704136
    [No Abstract]   [Full Text] [Related]  

  • 17. Deactivating cardioverter defibrillators near the end of life.
    BMJ; 2013 Jan; 346():f558. PubMed ID: 23364068
    [No Abstract]   [Full Text] [Related]  

  • 18. EOL considerations in defibrillator deactivation.
    Grassman D
    Am J Hosp Palliat Care; 2005; 22(3):179; author reply 179-80. PubMed ID: 15909779
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of cardiac devices as the end nears.
    Enck RE
    Am J Hosp Palliat Care; 2005; 22(1):7-8. PubMed ID: 15736599
    [No Abstract]   [Full Text] [Related]  

  • 20. "I felt like the angel of death": role conflicts and moral distress among allied professionals employed by the US cardiovascular implantable electronic device industry.
    Mueller PS; Ottenberg AL; Hayes DL; Koenig BA
    J Interv Card Electrophysiol; 2011 Dec; 32(3):253-61. PubMed ID: 21861198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.